BioSpace News Archive

VectivBio’s investor syndicate expands to include Surveyor Capital (a Citadel company), Cormorant Capital and Eventide Asset Management

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announces that biomarkers associated with clinical response in patients with r/r DLBCL treated with DPX-Survivac combination

OncXerna Therapeutics, Inc. announced that Laura Benjamin, Ph.D., Founder and CEO of OncXerna, will participate at the Jefferies Virtual London Healthcare Conference taking place November 17-19, 2020.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance, announced the pricing of its upsized initial public offering of 10,000,000 shares of common stock at a public offering price of $19.00 per share.

The team of medical experts offers breast cancer prevention, detection, diagnosis, treatment, and recovery with a unique patient-centered approach.

GYANT, the AI-powered virtual assistant company, today announced its first-to-market vaccine care navigation tool, GYANT Vaccine, anticipating impending health system strain following emergency use authorization of a COVID-19 vaccine

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, with its subsidiary Kemin Biologics, has signed an exclusive agreement with Pacific GeneTech (PGT) to license PGT’s TMH001 Eimeria vaccine for poultry

Neogen Corporation (NASDAQ: NEOG) announced today that it has launched a new food extraction method that expands the capabilities of select Reveal ® 3-D food allergen tests to include the direct testing of food products. Neogen’s new Reveal 3-D Food Buffer allows for the rapid screening of food and ingredient samples as low

Clough Capital Partners L.P., an independent boutique manager of alternative investment strategies, is pleased to announce that Dr. Noelle Tune, MD has joined the firm as a Director and a healthcare research analyst.

Magnolia Medical Technologies, Inc. – the trusted solution for reducing blood culture contamination – today announced the launch of its new Steripath® Micro Initial Specimen Diversion Device®.